Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Apr;10(4):307-17.
doi: 10.1038/nrd3410.

The resurgence of covalent drugs

Juswinder Singh  1 , Russell C Petter, Thomas A Baillie, Adrian Whitty
Affiliations
Review

The resurgence of covalent drugs

Juswinder Singh et al. Nat Rev Drug Discov. 2011 Apr.

Abstract

Covalent drugs have proved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project. There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium. This review surveys the prevalence and pharmacological advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.

PubMed Disclaimer

References

    1. Chem Res Toxicol. 2006 Jul;19(7):889-93 - PubMed
    1. Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12022-7 - PubMed
    1. Pharmacol Ther. 1999 May-Jun;82(2-3):207-18 - PubMed
    1. Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):923-46 - PubMed
    1. Nat Chem Biol. 2011 Jan;7(1):22-4 - PubMed

MeSH terms

Substances

LinkOut - more resources